NYSE:MDC M.D.C. Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding M.D.C. Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $31.45 +0.64 (+2.08%) (As of 06/24/2022 12:00 AM ET) Add Compare Share Today's Range$30.73▼$32.0750-Day Range$28.26▼$40.3752-Week Range$27.83▼$56.53Volume703,456 shsAverage Volume585,392 shsMarket Capitalization$2.24 billionP/E Ratio3.78Dividend Yield6.36%Price Target$47.67 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock Forecast (MarketRank)Overall MarketRank™3.37 out of 5 starsConstruction Sector2nd out of 134 stocksOperative Builders Industry2nd out of 19 stocksAnalyst Opinion: 3.1Community Rank: 3.7Dividend Strength: 3.3Insider Behavior: 4.2Valuation: 2.5 5 -4 -3 -2 -1 - 3.1 Analyst's Opinion Consensus RatingM.D.C. has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $47.67, M.D.C. has a forecasted upside of 51.6% from its current price of $31.45.Amount of Analyst CoverageM.D.C. has only been the subject of 2 research reports in the past 90 days. Previous Next 3.7 Community Rank Outperform VotesM.D.C. has received 283 “outperform” votes. (Add your “outperform” vote.)Underperform VotesM.D.C. has received 220 “underperform” votes. (Add your “underperform” vote.)Community SentimentM.D.C. has received 56.26% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about M.D.C. and other stocks. Vote “Outperform” if you believe MDC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend LeadershipM.D.C. is a leading dividend payer. It pays a dividend yield of 6.36%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthM.D.C. has only been increasing its dividend for 2 years.Dividend CoverageThe dividend payout ratio of M.D.C. is 24.01%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, M.D.C. will have a dividend payout ratio of 18.55% next year. This indicates that M.D.C. will be able to sustain or increase its dividend. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, M.D.C. insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $488,878.00 in company stock.Percentage Held by Insiders24.20% of the stock of M.D.C. is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions83.86% of the stock of M.D.C. is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for M.D.C. are expected to grow by 1.22% in the coming year, from $10.65 to $10.78 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of M.D.C. is 3.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 17.11.Price to Earnings Ratio vs. SectorThe P/E ratio of M.D.C. is 3.78, which means that it is trading at a less expensive P/E ratio than the Construction sector average P/E ratio of about 12.07.Price to Book Value per Share RatioM.D.C. has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About M.D.C. (NYSE:MDC)M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, Washington, Colorado, Idaho, Utah, Maryland, Pennsylvania, Virginia, Tennessee, and Florida. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is headquartered in Denver, Colorado.Read More MDC Stock News HeadlinesJune 16, 2022 | marketbeat.comDirt-Cheap Dividends: Low P/Es, Yields Up to 6.1%June 25, 2022 | au.finance.yahoo.comDoes Mediclinic International (LON:MDC) Deserve A Spot On Your Watchlist? - Yahoo Finance AustraliaJune 24, 2022 | finance.yahoo.comM.D.C. HOLDINGS ANNOUNCES 2022 SECOND QUARTER EARNINGS RELEASE SCHEDULE AND CONFERENCE CALLJune 24, 2022 | nasdaq.comDream Finders Homes (DFH) Surges 9.5%: Is This an Indication of Further Gains? - NasdaqJune 23, 2022 | finance.yahoo.comOleochemicals Market to reach USD 57.29 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.3% | Detailed MDC Research Report - Yahoo FinanceJune 23, 2022 | finance.yahoo.comNewborn Screening Market Exclusive Report | By Prodcut Consumable Segment will Dominate the Industry to 2030 - MDC Research - Yahoo FinanceJune 23, 2022 | globenewswire.comNewborn Screening Market Exclusive Report | By Prodcut Consumable Segment will Dominate the Industry to 2030 - MDC Research - GlobeNewswireJune 23, 2022 | globenewswire.comOleochemicals Market to reach USD 57.29 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.3% | Detailed MDC Research Report - GlobeNewswireJune 23, 2022 | globenewswire.comLiquid Biopsy Market to reach USD 21.27 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.89% - MDC Research - GlobeNewswireJune 23, 2022 | globenewswire.comHome Healthcare Market | Therapeutic Segment is Expected to Generate Highest Revenue Share to 2030 - MDC Research - GlobeNewswireJune 21, 2022 | globenewswire.comProppants Market | Proppants Price Expected to Rise from USD 0.76 to 2.11 per Kg by 2030 - MDC Research Study - GlobeNewswireJune 21, 2022 | finance.yahoo.comProppants Market | Proppants Price Expected to Rise from USD 0.76 to 2.11 per Kg by 2030 - MDC Research Study - Yahoo FinanceJune 20, 2022 | finance.yahoo.comRichmond American Debuts New Community and Homes in PuebloSee More Headlines Industry, Sector and Symbol Stock ExchangeNYSE Industry Operative builders Sub-IndustryHomebuilding SectorConstruction Current SymbolNYSE:MDC CUSIP55267610 CIK773141 Webwww.mdcholdings.com Phone(303) 773-1100Fax303-771-3461Employees2,080Year Founded1972Company Calendar Last Earnings4/28/2022Ex-Dividend for 5/25 Dividend5/10/2022Dividend Payable5/25/2022Today6/26/2022Next Earnings (Estimated)8/04/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$47.67 High Stock Price Forecast$77.00 Low Stock Price Forecast$27.00 Forecasted Upside/Downside+51.6%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$8.329990 Trailing P/E Ratio3.78 Forward P/E Ratio2.95 P/E GrowthN/ANet Income$573.66 million Net Margins11.24% Pretax Margin14.88% Return on Equity24.22% Return on Assets12.64% Debt Debt-to-Equity Ratio0.61 Current Ratio7.20 Quick Ratio1.49 Sales & Book Value Annual Sales$5.25 billion Price / Sales0.43 Cash Flow$8.57 per share Price / Cash Flow3.67 Book Value$36.75 per share Price / Book0.86Miscellaneous Outstanding Shares71,160,000Free Float53,941,000Market Cap$2.24 billion OptionableOptionable Beta1.34 Social Links M.D.C. Frequently Asked Questions Should I buy or sell M.D.C. stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" M.D.C. stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares. View analyst ratings for M.D.C. or view top-rated stocks. What is M.D.C.'s stock price forecast for 2022? 4 brokers have issued 12 month target prices for M.D.C.'s shares. Their MDC stock forecasts range from $27.00 to $77.00. On average, they predict M.D.C.'s stock price to reach $47.67 in the next year. This suggests a possible upside of 51.6% from the stock's current price. View analysts' price targets for M.D.C. or view top-rated stocks among Wall Street analysts. How has M.D.C.'s stock price performed in 2022? M.D.C.'s stock was trading at $55.83 at the beginning of 2022. Since then, MDC shares have decreased by 43.7% and is now trading at $31.45. View the best growth stocks for 2022 here. When is M.D.C.'s next earnings date? M.D.C. is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for M.D.C.. How were M.D.C.'s earnings last quarter? M.D.C. Holdings, Inc. (NYSE:MDC) announced its earnings results on Thursday, April, 28th. The construction company reported $2.02 EPS for the quarter, beating the consensus estimate of $1.90 by $0.12. The construction company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.22 billion. M.D.C. had a trailing twelve-month return on equity of 24.22% and a net margin of 11.24%. The company's quarterly revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.51 EPS. View M.D.C.'s earnings history. How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.? M.D.C. announced a quarterly dividend on Wednesday, April 27th. Stockholders of record on Wednesday, May 11th will be paid a dividend of $0.50 per share on Wednesday, May 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 6.36%. The ex-dividend date of this dividend is Tuesday, May 10th. View M.D.C.'s dividend history. Is M.D.C. a good dividend stock? M.D.C.(NYSE:MDC) pays an annual dividend of $2.00 per share and currently has a dividend yield of 6.36%. MDC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. M.D.C. has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of M.D.C. is 24.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 18.55% next year. This indicates that M.D.C. will be able to sustain or increase its dividend. View M.D.C.'s dividend history. Who are M.D.C.'s key executives? M.D.C.'s management team includes the following people: Mr. Larry A. Mizel, Exec. Chairman (Age 79, Pay $9.08M)Mr. David D. Mandarich, Pres, CEO & Director (Age 74, Pay $7.01M)Mr. Robert Nathaniel Martin, Sr. VP, CFO & Principal Accounting Officer (Age 43, Pay $2.36M)Ms. Leslie B. Fox, Consultant (Age 63, Pay $251k)Mr. Ryan Berry, Director of Corp. Fin. & Assistant TreasurerMr. Kelly Taga, Chief Information Officer & VPMs. Krista Montgomery, Sr. VP & Chief HR OfficerMr. Jack Gallagher, Regional Pres of Maryland, Virginia & Florida - Richmond American Homes Corp.Ms. Dawn Huth, Sr. VP of National Fin. - Richmond American HomesMs. Natasha Gandhi, Sr. Division Pres of South & Central Colorado Who are some of M.D.C.'s key competitors? Some companies that are related to M.D.C. include D.R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), Meritage Homes (MTH), KB Home (KBH), Tri Pointe Homes (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV). View all of MDC's competitors. What other stocks do shareholders of M.D.C. own? Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM). What is M.D.C.'s stock symbol? M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC." Who are M.D.C.'s major shareholders? M.D.C.'s stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.54%), Vanguard Group Inc. (9.01%), Dimensional Fund Advisors LP (5.96%), State Street Corp (3.54%), Hamlin Capital Management LLC (2.84%) and Principal Financial Group Inc. (1.86%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey. View institutional ownership trends for M.D.C.. Which major investors are selling M.D.C. stock? MDC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., LSV Asset Management, Jane Street Group LLC, Bahl & Gaynor Inc., Healthcare of Ontario Pension Plan Trust Fund, Mondrian Investment Partners LTD, SG Americas Securities LLC, and Bank of America Corp DE. Company insiders that have sold M.D.C. company stock in the last two years include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Robert Nathaniel Martin, and Staci M Woolsey. View insider buying and selling activity for M.D.C. or view top insider-selling stocks. Which major investors are buying M.D.C. stock? MDC stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Hamlin Capital Management LLC, Invesco Ltd., First Trust Advisors LP, JPMorgan Chase & Co., Vanguard Group Inc., Cibc World Market Inc., and Edgestream Partners L.P.. View insider buying and selling activity for M.D.C. or or view top insider-buying stocks. How do I buy shares of M.D.C.? Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is M.D.C.'s stock price today? One share of MDC stock can currently be purchased for approximately $31.45. How much money does M.D.C. make? M.D.C. (NYSE:MDC) has a market capitalization of $2.24 billion and generates $5.25 billion in revenue each year. The construction company earns $573.66 million in net income (profit) each year or $8.329990 on an earnings per share basis. How many employees does M.D.C. have? M.D.C. employs 2,080 workers across the globe. When was M.D.C. founded? M.D.C. was founded in 1972. How can I contact M.D.C.? M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The official website for M.D.C. is www.mdcholdings.com. The construction company can be reached via phone at (303) 773-1100, via email at [email protected], or via fax at 303-771-3461. This page (NYSE:MDC) was last updated on 6/26/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here